| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/03/2008 | EP1962805A2 Lipid-based compositions of antiinfectives for treating pulmonary infections |
| 09/03/2008 | EP1962804A1 Aerosol formulation for inhalation containing an anticholinergic agent |
| 09/03/2008 | EP1962780A1 Aqueous-alcoholic depigmenting gel |
| 09/03/2008 | EP1962778A2 Improved oral compositions comprising zinc citrate and/or tocopherol agents |
| 09/03/2008 | EP1962622A1 Composition based on triethyl citrate for the prevention of enzymatic hydrolysis of triglycerides |
| 09/03/2008 | EP1962614A1 Use of 25-hydroxy vitamin d3 to improve vitality of animals |
| 09/03/2008 | EP1962605A2 2-arylthiazole derivatives as cxcr3 receptor modulators |
| 09/03/2008 | EP1962601A2 Fused aminopiperidines as dipeptidyl peptidase-4 inhibitors for the treatment or prevention of diabetes |
| 09/03/2008 | EP1962600A2 Metronidazole cocrystals and imipramine cocrystals |
| 09/03/2008 | EP1962598A2 Homogeneous paste formulations |
| 09/03/2008 | EP1962597A2 Purine derivatives and methods of use thereof |
| 09/03/2008 | EP1962596A2 Trioxane dimers having high anticancer and long-lasting antimalarial activities |
| 09/03/2008 | EP1962589A2 Synergistic combinations of norketamine and opioid analgesics |
| 09/03/2008 | EP1919863A4 Process for the production of bicalutamide |
| 09/03/2008 | EP1909835A4 Methods and compositions for treating female infertility using clomiphene |
| 09/03/2008 | EP1879581B1 4-PHENYL-5-0X0-l,4,5,6,7,8-HEXAHYDR0QËIN0LINE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF INFERTILITY |
| 09/03/2008 | EP1817022A4 Methods for increasing the immune response in an animal |
| 09/03/2008 | EP1793836A4 Ophthalmic compositions including lubricant, deturgescent agent, and glycosaminoglycan and methods of using the same |
| 09/03/2008 | EP1761497B1 Azadecalin glucocorticoid receptor modulators |
| 09/03/2008 | EP1740094A4 Pyridyl-substituted porphyrin compounds and methods of use thereof |
| 09/03/2008 | EP1730112B1 3-((hetero)arylsulfonyl)-8'[ (aminoalkyl)oxy]quinolines as 5-ht6 receptor antagonists for the treatment of cns disorders |
| 09/03/2008 | EP1718613B1 Pyridine derivatives and their use as cb2 receptor modulators |
| 09/03/2008 | EP1703913A4 Use of ribose in recovery from anaesthesia |
| 09/03/2008 | EP1701933B1 Novel compounds |
| 09/03/2008 | EP1699447B1 Compositions comprising pantothenic acid or derivatives thereof and their use for stimulating appetite |
| 09/03/2008 | EP1694362A4 Improved parasiticide composition |
| 09/03/2008 | EP1693067A4 Pharmaceutical anti-herpetic composition, method for producing a dosage form based thereon and method for the use thereof |
| 09/03/2008 | EP1689404B1 Combination of et-743 with 5-fluorouracil pro-drugs for the treatment of cancer |
| 09/03/2008 | EP1641774B1 Pentafluoroalkanesulfinyl naphthalenes and related estrogen receptor modulators |
| 09/03/2008 | EP1636217B1 2-imidazo-benzothiazoles as adenosine receptor ligands |
| 09/03/2008 | EP1626720B1 4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitors |
| 09/03/2008 | EP1604659B1 Tablet containing water-absorbing amino acid |
| 09/03/2008 | EP1603909A4 Linear chain substituted monocyclic and bicyclic derivatives as factor xa inhibitors |
| 09/03/2008 | EP1594456B1 Use of a composition comprising vitamin k1 oxide or a derivative thereof for the treatment and/or the prevention of mammal dermatological lesions |
| 09/03/2008 | EP1587789B1 Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases |
| 09/03/2008 | EP1556016B1 Multilayer dosage forms, which contain active substances and which comprise a neutral core, and an inner and outer coating consisting of methacrylate copolymers and methacrylate monomers |
| 09/03/2008 | EP1545516B1 Topical formulation comprising at least 10% of metronidazole in white petrolatum and its use in the anal and rectal region |
| 09/03/2008 | EP1545500A4 Paclitaxel composition for the intravesical treatment of bladder tumor and preparation method thereof |
| 09/03/2008 | EP1542672B1 R-bambuterol, its preparation and therapeutic uses |
| 09/03/2008 | EP1517675B1 Composition for treatment of inflammatory disorders |
| 09/03/2008 | EP1496759B1 Compositions comprising protein and fatty acid and processes of their preparation |
| 09/03/2008 | EP1496758B1 Compositions comprising milk protein concentrate and fatty acid and processes of their preparation |
| 09/03/2008 | EP1496757B1 Compositions comprising short and long chain fatty acids and methods of their use for the management of body weight |
| 09/03/2008 | EP1494680B1 Use of carbon-2-modified-vitamin d analogs to induce the formation of new bone |
| 09/03/2008 | EP1480647B1 Mono-ester and asymmetrically substituted di-ester pro-drugs of the dopamine d1 receptor agonists |
| 09/03/2008 | EP1474143B1 Methods and compositions for treating male erectile dysfunction |
| 09/03/2008 | EP1465626B1 Pharmaceutical compositions (kit) comprising dihydropyridinone compounds and an immunoregulatory (or an antiinflammatory) agent and their uses |
| 09/03/2008 | EP1448234B1 Formulations comprising a cephalosporin compound and their use in treating bacterial infections in cats and dogs |
| 09/03/2008 | EP1415667B1 Pancreatic juice secretion regulators comprising lpa receptor controller |
| 09/03/2008 | EP1411879B1 A composition and uses therefor for combating hangover |
| 09/03/2008 | EP1389094B1 Delivery of sedative-hypnotics trough an inhalation route |
| 09/03/2008 | EP1385551B1 Antineoplastic combinations comprising cci-779 (rapamycin derivative) together with gemcitabine or fluorouracil |
| 09/03/2008 | EP1370253B1 Use of alpha, beta unsaturated aryl sulfones for protecting cells and tissues from ionizing radiation toxicity |
| 09/03/2008 | EP1363617B1 Cyanoacrylate compositions for therapeutic treatment of wounds requiring revision |
| 09/03/2008 | EP1343781B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 09/03/2008 | EP1339398B1 Treatment of motor fluctuations with 5-hydroxytryptamine 1a receptor activity enhancing compounds |
| 09/03/2008 | EP1334720B1 Nateglinide-containing preparations |
| 09/03/2008 | EP1311708B1 Method for identifying substances useful for treating inflammation using the response element to the ikappabaplha ror receptor |
| 09/03/2008 | EP1311480B1 New amidino derivatives and their use as thrombin inhibitors |
| 09/03/2008 | EP1299424B1 COLD WATER SOLUBLE $g(b)-GLUCAN PRODUCT AND PROCESS FOR PREPARING THE SAME |
| 09/03/2008 | EP1283038B1 Compositions normalizing circadian rhythm |
| 09/03/2008 | EP1262477B1 Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredient |
| 09/03/2008 | EP1261349B1 Compounds with chelation affinity and selectivity for first transition series elements and their use |
| 09/03/2008 | EP1257541B1 Polypharmacophoric agents |
| 09/03/2008 | EP1253943B1 Photodynamic therapy for treating conditions of the eye |
| 09/03/2008 | EP1131070B1 Pharmaceutical composition for modified release of an insulin sensitiser and metformin |
| 09/03/2008 | EP1126869B1 Methods for regulating angiogenesis and vascular integrity using the trk receptor ligands bdnf, nt-3 and nt-4 |
| 09/03/2008 | EP1121129B1 METHOD FOR TREATING DIABETES EMPLOYING AN aP2 INHIBITOR AND ASSOCIATED COMBINATIONS |
| 09/03/2008 | EP1044687B1 Powders containing tocotrienols and tablets prepared by compression molding the same |
| 09/03/2008 | EP1042293B9 Substituted pyridine and pyridazine compounds and their pharmaceutical use |
| 09/03/2008 | EP0906340B2 Purification of factor viii complex by immunoaffinity chromatography |
| 09/03/2008 | EP0852463B1 Myogenic differentiation of human mesenchymal stem cells |
| 09/03/2008 | EP0804576B1 A novel haemopoietin receptor |
| 09/03/2008 | EP0789575B1 Peripheral nervous system specific sodium channels, dna encoding therefor, drug screening, and methods of making and using thereof |
| 09/03/2008 | EP0758252B1 TIN-117m-CONTAINING RADIOTHERAPEUTIC AGENTS |
| 09/03/2008 | EP0710116B1 Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells |
| 09/03/2008 | CN101258166A Antibody combining with STEAP-1 protein and deriving molecule thereof |
| 09/03/2008 | CN101258159A Novel c18 modified retrosteroids as progesterone receptor modulator compounds |
| 09/03/2008 | CN101258157A Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
| 09/03/2008 | CN101258156A Amorphous and crystalline forms of dorzolamide hydrochloride and processes of making same |
| 09/03/2008 | CN101258155A Tetracyclic indole derivatives as antiviral agents |
| 09/03/2008 | CN101258154A Pyrazolo [3,4-d]azepine derivatives as histamine h3 antagonists |
| 09/03/2008 | CN101258153A Cysteine protease inhibitors |
| 09/03/2008 | CN101258152A Pyridopyrimidine derivatives as PDE4 inhibitors for the treatment of inflammatory and immune diseases |
| 09/03/2008 | CN101258150A Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 09/03/2008 | CN101258149A Thiazole derivatives and use thereof |
| 09/03/2008 | CN101258148A 8-phenyl-7,8-dihydropyridines[2,3-d]pyrimidine-7-ketone and uses as medicament |
| 09/03/2008 | CN101258147A Derivatives of 4-piperazin-1-yl-4-benz0[B]thiophene suitable for the treatment of CNS disorders |
| 09/03/2008 | CN101258146A Pharmaceutical dosage forms and compositions comprising lecozotan |
| 09/03/2008 | CN101258145A Stereoisomeric pyridyl and pyridonyl compounds and methods for the treatment of gastrointestinal and central nervous system disorders |
| 09/03/2008 | CN101258144A Aminoaryl sulphonamide derivatives as functional 5-ht6 ligands |
| 09/03/2008 | CN101258143A Benzylpiperazine derivatives and their medical use |
| 09/03/2008 | CN101258142A 2-aminoaryl pyridines as protein kinases inhibitors |
| 09/03/2008 | CN101258140A Benzo (B) cycloprop (D) pyran-2-(1H)-one derivatives |
| 09/03/2008 | CN101258138A Phenoxypropylpiperidines and -pyrrolidines and their use as histamine h3-receptor ligands |
| 09/03/2008 | CN101258137A Dicycloalkyl urea glucokinase activators |
| 09/03/2008 | CN101258136A New compounds, process for their preparation, intermediates, pharmaceutical compositions and their use in the treatment of 5-HT6 mediated disorders such as alzheimer s desease, cognitive disorders, co |
| 09/03/2008 | CN101258135A New compounds, process for their preparation, intermediates, pharmaceutical compositions and their use in the treatment of 5-HT6 mediated disorders such as alzheimer desease, cognitive disorders, cogn |
| 09/03/2008 | CN101258134A 2-(4-oxo-4H-quinazolin-3-yl) acetamides and their use as vasopressin V3 antagonists |
| 09/03/2008 | CN101258133A Pyrimidine derivatives and their use as kcnq potassium channels openers |